Lipella Pharmaceuticals Inc. today announced the appointment of David L. Lucchino, co-founder and former Chief Executive Officer of Semprus BioSciences, to the company’s Board of Directors. Semprus BioSciences was acquired in May 2012 for $80M.
Mr. Lucchino co-founded Semprus BioSciences with Massachusetts Institute of Technology’s Institute Professor, Robert S. Langer, Sc.D., while earning his MBA as an Alfred P. Sloan Fellow.
Help employers find you! Check out all the jobs and post your resume.
